Insilico Medicine Reports Positive First-Half 2026 Financial Outlook

Insilico Medicine reported expected first-half 2026 revenue of approximately $102.5 million to $106.5 million and projected net profit of approximately $33.5 million to $39.5 million. On this page you can read the full post, open the connected company profile, view related posts, check likes and publication details.
  • Insilico Medicine reported expected first-half 2026 revenue of approximately $102.5 million to $106.5 million and projected net profit of approximately $33.5 million to $39.5 million. On this page you can read the full post, open the connected company profile, view related posts, check likes and publication details.